Lipid polymeric nanoparticles modified with tight junction-modulating peptides promote afatinib delivery across a blood –brain barrier model

ConclusionTJ-modulating peptide-modified LPN could be a prospective platform for the delivery of chemotherapeutics across the BBB to the brain for the potential treatment of the BM of NSCLC.
Source: Cancer Nanotechnology - Category: Cancer & Oncology Source Type: research